Breaking News, Financial News

Financial Report: WuXi PharmaTech

Manufacturing services up 10% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi PharmaTech   2Q Revenues: $194.1 million (+19%) 2Q Earnings: $19.4 million (-34%) YTD Revenues: $374.2 million (+21%) YTD Earnings: $37.2 million (-21%) Comments: Laboratory services grew 18% to $123.5 million in the quarter. Small-molecule manufacturing services increased 10% to $45.9 million. Biologics Services Grew 48% to $18.3 million. New business and other grew 43% to $6.4 million....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters